Genflow Biosciences (LON:GENF) Releases Quarterly Earnings Results

Genflow Biosciences (LON:GENF) released its quarterly earnings data on Tuesday. The company reported GBX (0.08) earnings per share for the quarter, Digital Look Earnings reports. Genflow Biosciences had a negative net margin of 170.64% and a positive return on equity of 332.06%.

Genflow Biosciences Trading Up 0.2%

Shares of LON GENF opened at GBX 1.98 on Tuesday. The company has a market cap of £11.21 million, a price-to-earnings ratio of -5.96 and a beta of 2.29. Genflow Biosciences has a 12 month low of GBX 0.90 and a 12 month high of GBX 3.12. The stock has a 50-day moving average price of GBX 2.01 and a two-hundred day moving average price of GBX 2.08.

About Genflow Biosciences

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.